A Phase 1 clone’s armor and helmet exudes nearly unparalleled swagger, and their stylish attire fortifies the aesthetic of Star Wars combat scenes. [RELATED – 10 Coolest Star Wars Bounty Hunters] ...

Explore the evolution of Clone Trooper armor from Phase I to Phase II, highlighting key design changes and tactical upgrades. This video breaks down the differences in helmet structure, armor ...

Conference Call Sionna will host a conference call today, June 4, 2025, at 8:00 a.m. ET to discuss the positive Phase 1 results for SION-719 and SION-451 and the Company’s development strategy.

BioNTech and Pfizer have announced that they are initiating a phase 1 study to evaluate a single dose mRNA-based combination vaccine candidate against influenza and COVID-19 – a novel ...

Corvus Pharmaceuticals announced interim data from its Phase 1 clinical trial of soquelitinib for moderate to severe atopic dermatitis, indicating that Cohort 3 (200 mg BID) showed earlier and ...

Phase 1 Drilling began on April 28 th and was executed by Kluane Drilling, based out of Whitehorse YT. A total of 2,354.70 meters of drilling was completed across 13 holes which varied from 50-350 ...

Innovent Biologics presents data from phase 1 PoC study of IBI363 to treat advanced NSCLC at 2025 ASCO San Francisco Friday, June 6, 2025, 18:00 Hrs [IST] Innovent Biologics, Inc. (Innovent), a ...

Among the patients with PD-L1 TPS<1%, IBI363 demonstrated outstanding efficacy signals: in the 1/1.5 mg/kg group (N=10), the confirmed ORR was 30.0% and the DCR was 90.0%, while that of the 3 mg ...

Eyestem has announced the completion of its phase 1 study for its investigational retinal pigment epithelium (RPE) cell therapy, Eyecyte-RPE. The company has submitted the results to the Central Drugs ...

Sulzbacher will begin construction on Phase 1 of Sulzbacher Enterprise Village after closing on financing of the $37 million project, the nonprofit homeless services provider announced June 5. Phase 1 ...

The phase 2 trial, called AGAVE-201, that led to Niktimvo’s approval last year enrolled patients with recurrent or refractory cGVHD. The FDA-approved label for the drug says that infusion-related ...